Published in Drug Law Weekly, May 6th, 2008
The Oman Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Oman's pharmaceuticals and healthcare industry.
Oman's drug market is expected to grow strongly over the forecast period (2008-2012) to reach a value of US$181.7mn by 2012. Growth in the pharmaceutical sector will be aided by a strong healthcare system, which is regarded as one of the best funded and most efficient in the Middle East and Africa (MEA). The drug market will...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.